We need more studies to evaluate the relationship between changes in angiopoietin-Tie2 and NO expression on cancer outcomes after tumor resection and to explore potential clinical applications of angiopoietin-Tie2 and NO signaling in cancer prevention and treatment. The gene discussed is TEK; the disease is cancer.